menu search

Egyptian health tech yodawy raises $16m, backed by delivery hero ventures

Without proper government-led public health initiatives, healthcare expenditures, including insurance and phar...

February 9, 2023, 2:00 am

Eylea® (aflibercept) injection approved as the first pharmacologic treatment for preterm infants with retinopathy of prematurity (rop) by the fda

ROP is a leading cause of childhood blindness worldwide EYLEA now approved to treat five retinal conditions caused by ocular angiogenesis TARRYTOWN, N...

February 8, 2023, 11:45 pm

Fulcrum therapeutics to participate at the upcoming svb securities global biopharma conference

CAMBRIDGE, Mass., Feb. 08, 2023 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage bio...

February 8, 2023, 10:00 pm

Cara therapeutics announces results from the komfort phase 2 trial of oral difelikefalin for the treatment of pruritus in notalgia paresthetica published in the new england journal of medicine

Publication underscores the importance of data in underrecognized neuropathic itch disorder which lacks an approved treatment STAMFORD, Conn., Feb. 08...

February 8, 2023, 10:00 pm

Syneos health schedules fourth quarter and full year 2022 earnings call for thursday, february 16th, 2023

MORRISVILLE, N.C., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated bio...

February 8, 2023, 9:41 pm

Dice therapeutics to participate at upcoming investor conferences

SOUTH SAN FRANCISCO, Calif., Feb. 08, 2023 (GLOBE NEWSWIRE) — DICE Therapeutics, Inc. (Nasdaq: DICE), a biop...

February 8, 2023, 9:05 pm

Vertex pharmaceuticals: pioneering scientific advances to tackle serious diseases

Vertex pharmaceuticals focuses on creating transformative medicines for serious diseases, with a specia...

February 8, 2023, 6:52 pm

Vanda pharmaceuticals inc. (vnda) q4 2022 earnings call transcript

Vanda pharmaceuticals Inc. (NASDAQ:VNDA ) Q4 2022 Earnings Conference Call February 8, 2023 4:30 AM ET ...

February 8, 2023, 6:20 pm

Bayer's stock rallies after naming roche exec as new ceo

U.S.-listed shares of Bayer AG BAYRY, +5.72% BAYER, +1.09% rallied about 5% in trading on Wednesday after the German ...

February 8, 2023, 2:12 pm

Datacubed health announces new board member, mark blumling

Leading Life Sciences and Biopharmaceutical Executive Joins Board of Directors, Bringing Extensive Indu...

February 8, 2023, 2:09 pm

Factbox: bayer's new ceo: long-time roche, genentech executive, bill anderson

Bayer bowed to investor pressure on Wednesday and named Bill Anderson, most recently head of Roche's pharmaceu...

February 8, 2023, 2:03 pm

Eton pharmaceuticals, inc. (eton) upgraded to strong buy: here's what you should know

Eton pharmaceuticals, Inc. (ETON) might move higher on growing optimism about its earnings prospects, w...

February 8, 2023, 1:33 pm

Teva pharmaceutical industries limited (teva) q4 2022 earnings call transcript

Teva pharmaceutical Industries Limited (NYSE:TEVA ) Q4 2022 Earnings Conference Call February 8, 2023 8...

February 8, 2023, 12:21 pm

Vertex (vrtx) beats on q4 earnings & sales, '23 view encouraging

Vertex pharmaceuticals' (VRTX) four-quarter 2022 earnings and sales beat estimates. VRTX also issues be...

February 8, 2023, 12:03 pm

Why teva pharmaceutical stock is sliding today

Investors were disappointed with the drugmaker's 2023 outlook....

February 8, 2023, 12:01 pm

Erasca: potential strong upside ahead

Erasca, Inc. is a clinical-stage biopharmaceutical developer of therapies for patients with RAS/MAPK pa...

February 8, 2023, 11:21 am

Bentonite market size to surpass usd 2.05 billion by 2030 at 4.12% cagr – report by market research future (mrfr)

Bentonite Market Insights and Industry Analysis by Product (Sodium Bentonite, Calcium, Bentonite, Sulphur Bentonite, Others), By application ( Foundry...

February 8, 2023, 11:17 am

Is invesco dynamic pharmaceuticals etf (pjp) a strong etf right now?

Smart Beta ETF report for PJP...

February 8, 2023, 7:32 am

Beat the dow jones with this unstoppable dividend stock

This pharmaceutical company has outperformed the Dow Jones index over the last 10 years....

February 8, 2023, 5:50 am

Collegium pharmaceutical, inc. prices upsized $210.0 million convertible senior notes offering

STOUGHTON, Mass., Feb. 07, 2023 (GLOBE NEWSWIRE) — Collegium pharmaceutical, Inc. (Nasdaq: COLL) toda...

February 8, 2023, 2:54 am


Search within

Pages Search Results: